Why Arcutis Biotherapeutics (ARQT) Is Up 23.9% After Expanding ZORYVE to Pediatric Atopic Dermatitis
Arcutis Biotherapeutics recently launched ZORYVE cream 0.05% in the United States for mild to moderate atopic dermatitis in children aged 2 to 5, expanding its ZORYVE portfolio following FDA approval ...
James Howells lost $800 million in bitcoin to a landfill. Now, his relentless quest to recover it is a wild mix of tech, ...
XDA Developers on MSN
I built a second brain with AFFiNE, and it's the best thing I've ever done for my productivity
AFFiNE is an open-source productivity app with a workspace that blends structured note-taking with visual thinking. It’s a ...
It helps journalists verify hypotheses, reveal hidden insights, follow the money, scale investigations, and add credibility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results